Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 24, 2017
Pharmacy Choice - News - Front Page Healthcare News - March 24, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/31/15 - "Intelligent Health Home Monitoring System Supporting Congestive Heart Failure Self-Care" in Patent Application Approval Process (USPTO 20150356263)
By a News Reporter-Staff News Editor at Politics& Government Week A patent application by the inventors Chatterjee, Samir; Lee, Edward Kuang-Yu; Alluhaidan, Ala; Alnosayan, Nagla Sulaiman, filed on June 9, 2015, was made available online on December 17, 2015, according to news reporting originating from Washington, D.C., by VerticalNews correspon
12/31/15 - Blue Cross offers free house calls, health tutorials, to keep down ACA costs [The News & Observer (Raleigh, N.C.)]
Others ask how their name popped up on the Blue Cross call list. Blue Cross, the state's largest health insurer, is engaging in an experiment that may one day become standard practice in private health insurance, as the industry contends with rising costs. Using a computer algorithm to identify customers, Blue Cross is deploying teams of nurses and
12/31/15 - Carondelet, BlueCross reach last-minute deal [The Arizona Daily Star, Tucson]
Dec. 31 At the eleventh hour, BlueCross BlueShield of Arizona and Carondelet Health Network have signed a four-year contract, putting to rest fears that customers of the state's largest insurer could lose in-network access to Carondelet doctors and facilities. The agreement includes all Carondelet hospitals, employed physicians, ambulatory surger
12/31/15 - Clovis Oncology Receives Notification of PDUFA Extension for Rociletinib
By a News Reporter-Staff News Editor at Politics& Government Week Clovis Oncology, Inc. announced that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act date for Clovis' New Drug Application for rociletinib by the standard extension period of three months with the new goal date of June 28, 2016. Clovis Oncology
12/31/15 - Data on Neuroendocrine Cancer Reported by Researchers at S. Orsola-Malpighi University Hospital (Prognostic Value of Ga-68-DOTANOC PET/CT SUVmax in...
Data on Neuroendocrine Cancer Reported by Researchers at S. Orsola-Malpighi University Hospital. According to news reporting from Bologna, Italy, by VerticalNews journalists, research stated, "This study was performed to investigate the role of Ga-68-DOTANOC SUVmax as a potential prognostic factor in patients with pancreatic neuroendocrine tumor.
12/31/15 - Deep dive into the Healthcare System and Medical Device Market in Argentina - report incl. surgical procedures
This TforG report includes the Surgical Procedures Database with 620 surgical interventions, reported by the ICD-9 coding system in Argentina. Economic Outlook:- In spite of the forecasted acceleration in the global economy, for Argentina, the economic growth is expected to slow down in 2015 and make a slight recuperation to growth in 2016.- The
12/31/15 - Deep dive into the Healthcare System and Medical Device Market in the UAE - report incl. surgical procedures
This TforG report includes the Surgical Procedures Database with 620 surgical interventions, reported by the ICD-9 coding system in UAE. To add context to the surgical procedure volumes, the report provides written and numerical analysis on the current trends, size, changes and dynamics of the local markets. -Abu Dhabi is especially dependent on
12/31/15 - EISAI COMPLETES ACQUISITION OF CHINESE GENERIC PHARMACEUTICAL COMPANY LIAONING TIANYI BIOLOGICAL PHARMACEUTICAL
Release date- 28122015- Eisai Co., Ltd. announced today that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical Co., Ltd. previously announced on November 27, 2015, the conditions of transfer have been arranged, including receiving a new business license from the regulatory authority in Chi
12/31/15 - FDA awards stem cell co Pluristem orphan drug status [Globes, Tel Aviv, Israel]
Dec. 31 Israeli placenta-based cell therapy developer Pluristem Therapeutics Ltd. has been awarded orphan drug status by the US Food and Drug Administration for its PLX-PAD cells treatment for severe preeclampsia. We are encouraged by the US FDA designation that demonstrates Pluristem's commitment to the program and the potential promise it holds
12/31/15 - Federal Register Table of Contents
Bangor Hydro-Electric Co., et al., 81818 Federal Reserve System NOTICES Changes in Bank Control: Acquisitions of Shares of a Bank or Bank Holding Company, 81818-81819 Fiscal Service NOTICES Prompt Payment Interest Rate; Contract Disputes Act, 81880 Food and Drug Administration NOTICES Guidance: Emerging Postmarket Medical Device Signals, 81829-8183
12/31/15 - Global Blood Therapeutics Receives FDA Orphan Drug Designation for GBT440 in Sickle Cell Disease
Global Blood Therapeutics, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with significant unmet needs, announced today that the U.S. Food and Drug Administration has granted orphan drug designation for GBT440 for the treatment of patients with sickle cell disease.
12/31/15 - House To Vote On Bill To Repeal Obamacare, Defund Planned Parenthood
The legislation repeals key parts of Obamacare, including the individual and employer mandates, the so-called " Cadillac tax" and the medical device tax, and also halts federal funding for Planned Parenthood. The House passed similar legislation in October, but changes to the language of the Senate version of the bill require another vote in the Ho
12/31/15 - Japan : EISAI completes Acquisition of Chinese Generic Pharmaceutical company Liaoning Tianyi Biological Pharmaceutical Co., Ltd. [TendersInfo (India)]
Eisai Co., Ltd. announced today that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical Co., Ltd. previously announced on November 27, 2015, the conditions of transfer have been arranged, including receiving a new business license from the regulatory authority in China, and the acquisition
12/31/15 - Lack of professional leadership leads to inefficient Services at our healthcare facilities - Haroon Qasim
Haroon Qasim Managing Director of PharmEvo Pharmaceuticals. Shabbar Zaidi, Chartered Accountant and Senior Partner in A.F. Ferguson and Company was the other invited guest speaker on the occasion. We have some of the best hospitals in Karachi like Aga Khan University Hospital, Indus Hospital where their employees are fully involved in the Mission o
12/31/15 - Macon-based doctors' group seeks to improve care, reduce costs [The Macon Telegraph]
The law calls for an ACO to agree to manage the health care needs of at least 5,000 Medicare beneficiaries for at least three years. Georgia Physicians for Accountable Care was formed in mid-2013, and when doctors in the Macon area were first approached, "there was an overwhelming response," Barry said. " While the ACO was only required to get 5,00
12/31/15 - Pricing medical procedures ?the Utah way'
Vivian Lee is the CEO of University of Utah Health Care, and her accomplishments in Utah should serve as a model for Vermont. The "sticker price" for medical procedures in Utah, like here in Vermont, bore little to no relationship to the actual costs incurred by the hospital to perform them. Rolling up their sleeves in what she described as "the Ut
12/31/15 - Public Notification of Emerging Postmarket Medical Device Signals ("Emerging Signals"); Draft Guidance for Industry and Food and Drug Administration...
Public Notification of Emerging Postmarket Medical Device Signals; Draft Guidance for Industry and Food and Drug Administration Staff; Availability. SUMMARY: The Food and Drug Administration is announcing the availability of the draft guidance entitled "Public Notification of Emerging Postmarket Medical Device Signals." "Historically, FDA has...
12/31/15 - Rfa fibre for bipolar intraluminal application for varicose veins detail specification :us fda/european ce approved quality. inclusive of rental and... [TendersInfo (India)]
Tenders are invited for Rfa Fibre For Bipolar Intraluminal Application For Varicose Veins Detail Specification: Us Fda/ European Ce Approved Quality. Instructions/Remarks: All The Firms Participating In E-Tender Enquiry To Upload The Details Of The Offered Item In The Form Of Scanned Copy Of The Photo Of The Offered Item Showing All Relevant Detail
12/31/15 - Roche Submits Anti-Mullerian Hormone Assay for FDA Approval
By a News Reporter-Staff News Editor at Women's Health Weekly Roche announced that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian assay for use on Roche's full portfolio of laboratory analyzers. Alan Wright, Chief Medical Officer, Roche Diagnostics Corporation. The assay is
12/31/15 - RowdMap, Inc. CSO Joins Former Principal Deputy Administrator of CMS and CMO of Optum Labs to Translate Value of Public Data to Health Plans,... [Palestine Chronicle, The]
RowdMap, Inc. CSO Joins Former Principal Deputy Administrator of CMS and CMO of Optum Labs to Translate Value of Public Data to Health Plans, Risk-Bearing Providers. -Joshua Rosenthal, PhD, Chief Scientific Officer at RowdMap, Inc., joins Jonathan Blum, Former Principal Deputy Administrator of the Centers for Medicare and Medicaid and Paul Wallace,
12/31/15 - RowdMap, Inc. CSO Joins FTC, HHS and IMS to Help Health Care Companies Use Public Data to Improve Security, Project Costs and Take on Risk
Joshua Rosenthal, PhD, Chief Scientific Officer at RowdMap, Inc., joins Cora Han, Senior Attorney, Division of Privacy and Identity Protection, Federal Trade Commission; Christina Heide, Acting Deputy Director for Health Information Privacy, Office for Civil Rights, U.S. Department of Health& Human Services; and Kim Gray, Chief Privacy Officer, IMS
12/31/15 - Teligent, Inc. Announces Fourteenth & Fifteenth ANDA Submissions Of 2015
Teligent, Inc., a New Jersey- based specialty generic pharmaceutical company, today announced it has submitted its fourteenth and fifteenth abbreviated new drug applications to the U.S. Food and Drug Administration of 2015, which brings the Company's total number of ANDA submissions now pending at the FDA to thirty-three. We believe our current p
12/31/15 - TORRENT GETS US NOD FOR ARTHRITIS DRUG
Torrent Pharmaceutical Ltd has obtained the approval of the US Food and Drug Administration to launch a generic arthritis drug. The company will launch Celacoxib capsules in 50 mg, 100 mg, 200 mg and 400 mg strengths. The drug is the generic version of Celebrex capsules of Pfizer.
12/31/15 - U.S. Food & Drug Administration Grants Orphan Drug Designation to Pluristem's PLX-PAD Cells for Treatment of Severe Preeclampsia
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced that the U.S. Food and Drug Administration has granted the Company s PLX-PAD cells Orphan Drug Designation in the treatment of severe preeclampsia. Attainment of Orphan Drug Designation for our cells in severe preeclampsia exemplifies o
12/31/15 - United States : FDA approval for famotidine tablets gained by Aurobindo [TendersInfo (India)]
Aurobindo declared that the Food and Drug Administration approved its famotidine tablets in the 20 mg and 40 mg strengths to treat gastroesophageal reflux diesease and active duodenal ulcer. The permitted ANDA is bioequivalent and therapeutically equivalent to Pepcid tablets, 20 mg and 40 mg, from Valeant Pharmaceuticals. Famotidine tablets have an
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415